Ventyx Biosciences, Inc. (VTYX)
收市後：
| 前收市價 | 4.4800 |
| 開市 | 4.8400 |
| 買盤 | 4.0700 x 400 |
| 賣出價 | 4.9200 x 200 |
| 今日波幅 | 3.8450 - 5.0100 |
| 52 週波幅 | 1.8650 - 40.5800 |
| 成交量 | |
| 平均成交量 | 3,931,073 |
| 市值 | 288.342M |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.2400 |
| 業績公佈日 | 2024年3月25日 - 2024年3月29日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 10.80 |
ZacksWhat Makes Ventyx Biosciences (VTYX) a New Buy Stock
Ventyx Biosciences (VTYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Insider Monkey12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. Click to skip past our discussion of the biotech space and straight to the 5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. Alkermes plc (NASDAQ:ALKS), Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) and ImmunoGen, Inc. […]
Insider Monkey25 Biggest Stocks with Negative Beta
In this article, we will take a look at the 25 biggest stocks with negative beta. To see more such companies, go directly to 5 Biggest Stocks with Negative Beta. Stock markets were in see-saw mode before the Fed’s September decision on rate hikes. Markets gained on September 11 after positive data from China and […]
